About this document
Double-blind, placebo-controlled study of once daily venlafaxine XR in outpatients with generalized anxiety disorder _ J.T. Hask (1998) by Thomas Blum is a document available to read on EtoBox.
The document discusses the efficacy of fluoxetine and venlafaxine XR in treating anxiety disorders, particularly social phobia and generalized anxiety disorder (GAD). Fluoxetine showed significant reductions in anxious symptoms, while venlafaxine XR demonstrated advantages over placebo and buspirone in GAD patients without major depression. The studies indicate both medications are effective and well-tolerated, providing valuable treatment options for anxiety disorders.
- Author
- Thomas Blum
- Language
- EN